Replies to post #39830 on Amarantus Bioscience Holdings Inc (AMBS)

[zoomboom]

read... slowly and you will understand it better

" At the time of the acquisition, Synergen had $125 million in cash, so assuming everything else in the company was irrelevant, the value one could place on GDNF was only $115 million."

AMGEN Paid in 1994 $115 Million for inferior compound compared to MANF $115M then = $375 Million to $575 Million now.

[shab420]

You are right. That stock is going back to .0050 :)

[DonDaDa707]

This guy demanding information without a thanks or please.

One less WH.

See ya homey.

[joboggi]

The study was negative. It is as simple as that. If the p value was not sufficient the study was negative. If the study was positive they would have gotten funding by now.

Yes the behavioral study was pos but that is not enough. Yes the trend was positive, but that is not enough.